MNK: Mallinckrodt Plc – New Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-08 13D/A Hein Park Capital Management LP 7.85 27.37
02-14 13G/A Continental General Insurance Co 0.00 -100.00
02-14 13G/A Sculptor Capital LP 3.13 -11.12
02-14 13G/A Alta Fundamental Advisers LLC 1.50 -84.64
02-12 13G/A Flynn James E 6.50 -14.92
02-06 13G/A Hudson Bay Capital Management LP 7.48 39.87
02-06 13G Marathon Asset Management Lp 6.40
01-22 13D/A Silver Point Capital L.P. 5.50
01-04 13G/A Jpmorgan Chase & Co 0.00 -100.00
12-13 13G Goldentree Asset Management Lp 10.50
11-24 13D Squarepoint Ops LLC 6.60
11-17 13D/A Bracebridge Capital, LLC 5.60 -46.20
06-09 13G/A Federated Hermes, Inc. 3.92 -48.35

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2023
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023

(click for more detail)


Financial data and stock pages provided by
Fintel.io